Med-IQ
Managing Venous Thromboembolism: Exploring the Relationship Between Anticoagulant Treatment Decisions and Patient Outcomes
Simulation Simulation

Managing Venous Thromboembolism: Exploring the Relationship Between Anticoagulant Treatment Decisions and Patient Outcomes


Time to Complete:
1 hour
Released:
12/23/16
Expires:
1/22/18

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Simulation Simulation
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
1 hour

Released:
12/23/16

Expires:
1/22/18

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
Share on:
Simulation Simulation
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
1 hour
Released:
12/23/16
Expires:
1/22/18


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)


Overview: In this unique, case-based simulation, meet one patient who presents with signs and symptoms of venous thromboembolism (VTE) and another who presents with symptoms of pulmonary embolism. Step into the shoes of the treating clinician to develop optimal treatment plans. Consider how best to incorporate ACCP guidelines into patient management and optimize the use of direct oral anticoagulants and reversal agents.

Faculty

Francis Roosevelt Gilliam III, MD, FACP, FACC, FHRS

Palmetto Health University of South Carolina

Medical Group

Cardiology

Columbia, SC

Belinda N. Rivera-Lebron, MD

Assistant Professor of Medicine

Director, UPMC Acute Pulmonary Embolus (PE) Team

University of Pittsburgh

Pittsburgh, PA


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Francis Roosevelt Gilliam III, MD, FACP, FACC, FHRS, has indicated no real or apparent conflicts.
 
Laura Muttini
Ownership interest (stocks/stock options – excluding mutual funds): Abbott Laboratories, AbbVie Inc.
 
Belinda Natalia Rivera-Lebron, MD
Consulting fees/advisory boards: Gilead Sciences, Inc.
Contracted research: Actelion Pharmaceuticals Ltd

The peer reviewers and other activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Bristol-Myers Squibb and Pfizer Alliance.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.